-
Innovation Ranking
Innovation Ranking – Sumitomo Mitsui Financial Group Inc
Sumitomo Mitsui Financial Group Inc (SMFG) is a financial holding company that offers banking, financing, and asset management solutions. Its portfolio of banking products and related financial offerings includes card products, leasing, consumer finance, payment services, accounts, and deposit services. The company offers other services such as asset and wealth management, settlement, securities, data processing, management consulting, investment banking, and advisory. SMFG operates through a network of branches and representative offices, ATMs, and online portals and serves to individual, corporate,...
-
Innovation Ranking
Innovation Ranking – Sumitomo Metal Mining Co Ltd
Sumitomo Metal Mining Co Ltd (SMM) carries out the exploration and development of mineral resources and mining. It processes and produces mineral ores and metals. It manufactures and distributes rolled copper foil, copper and brass strips, battery materials, communication devices, lead frames, construction materials, paste and powder materials, package materials, board materials and printed wiring boards. The company also offers water recycling services, environmental business, and consulting services, domestic marine and transportation, precious metals recycling services and water treatment services....
-
Product Insights
Sumitomo Realty – Shibaura 2-Chome Condominium Tower – Tokyo
The Sumitomo Realty – Shibaura 2-Chome Condominium Tower – Tokyo involves the construction of a 118.46 meters height, 20,897.30m2, 34-story above-ground and two-story below-ground condominium tower on 0.16ha of land in Minato-ku, Tokyo, Japan. Equip yourself with the essential tools needed to make informed and profitable decisions with our Sumitomo Realty – Shibaura 2-Chome Condominium Tower – Tokyo report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3...
-
Sector Analysis
NewKuwait Power Market Trends and Analysis by Capacity, Generation, Transmission, Distribution, Regulations, Key Players and Forecast to 2035
Kuwait Power Market Report Overview The cumulative installed capacity in the power market in Kuwait was 20.3GW in 2023 and will achieve a CAGR of more than 4% during 2023-2035. Â The residential sector had the dominant share in power consumption in 2023 followed by the industrial sector. Kuwait Power Market Outlook, 2023-2035 (GW) The market research report discusses the Kuwait power market structure. It provides historical and forecast numbers for capacity, generation, and consumption up to 2035. The report also...
-
Thematic Analysis
NewBanking and Payments M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Banking & Payments Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pirmitegravir in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KSP-1007 in Ventilator Associated Pneumonia (VAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KSP-1007 in Ventilator Associated Pneumonia (VAP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KSP-1007 in Ventilator Associated Pneumonia (VAP) Drug Details: KSP-1007...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KSP-1007 in Complicated Intra-Abdominal Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KSP-1007 in Complicated Intra-Abdominal Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KSP-1007 in Complicated Intra-Abdominal Infections Drug Details: KSP-1007 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imifoplatin in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imifoplatin in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imifoplatin in Pancreatic Cancer Drug Details: PT-112 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ritlecitinib in Sezary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ritlecitinib in Sezary Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ritlecitinib in Sezary Syndrome Drug Details: Ritlecitinib (Litfulo) acts as an...